https://www.selleckchem.com/pr....oducts/lixisenatide.
Considering the design of some COVID-19 trials, we show that the empirical success rule yields treatment choices that are much closer to optimal than those generated by prevailing decision criteria based on hypothesis tests. Using trial findings to make near-optimal treatment choices rather than perform hypothesis tests should improve clinical decision making. Using trial findings to make near-optimal treatment choices rather than perform hypothesis tests should improve clinical decision making. To estimate the overall quality-adju
Like
Comment
Share
